- Home
- ICU vs EVGN Comparison
ICU vs EVGN Comparison
Compare ICU & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICU
- EVGN
- Stock Information
- Founded
- ICU 2018
- EVGN 1999
- Country
- ICU United States
- EVGN Israel
- Employees
- ICU N/A
- EVGN N/A
- Industry
- ICU Biotechnology: Pharmaceutical Preparations
- EVGN Agricultural Chemicals
- Sector
- ICU Health Care
- EVGN Industrials
- Exchange
- ICU Nasdaq
- EVGN Nasdaq
- Market Cap
- ICU 10.4M
- EVGN 9.7M
- IPO Year
- ICU N/A
- EVGN N/A
- Fundamental
- Price
- ICU $1.25
- EVGN $1.05
- Analyst Decision
- ICU
- EVGN Strong Buy
- Analyst Count
- ICU 0
- EVGN 1
- Target Price
- ICU N/A
- EVGN $12.00
- AVG Volume (30 Days)
- ICU 239.9K
- EVGN 19.7K
- Earning Date
- ICU 05-13-2025
- EVGN 05-22-2025
- Dividend Yield
- ICU N/A
- EVGN N/A
- EPS Growth
- ICU N/A
- EVGN N/A
- EPS
- ICU N/A
- EVGN N/A
- Revenue
- ICU $135,000.00
- EVGN $8,511,000.00
- Revenue This Year
- ICU $648.15
- EVGN $68.62
- Revenue Next Year
- ICU N/A
- EVGN $66.92
- P/E Ratio
- ICU N/A
- EVGN N/A
- Revenue Growth
- ICU N/A
- EVGN 50.90
- 52 Week Low
- ICU $1.21
- EVGN $1.04
- 52 Week High
- ICU $20.00
- EVGN $9.00
- Technical
- Relative Strength Index (RSI)
- ICU 30.70
- EVGN 22.67
- Support Level
- ICU $1.21
- EVGN $1.32
- Resistance Level
- ICU $2.57
- EVGN $1.28
- Average True Range (ATR)
- ICU 0.21
- EVGN 0.07
- MACD
- ICU -0.09
- EVGN -0.03
- Stochastic Oscillator
- ICU 2.94
- EVGN 2.44
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.